Approximately 80% Major Response Rate and Duration of Response Exceeding 16 Months in
Subset Analysis of Patients Treated with Iopofosine I 131 Immediately Post-BTKi Therapy
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.